Literature DB >> 22290440

MdmX is required for p53 interaction with and full induction of the Mdm2 promoter after cellular stress.

Lynn Biderman1, Masha V Poyurovsky, Yael Assia, James L Manley, Carol Prives.   

Abstract

The activity of the tumor suppressor p53 is tightly controlled by its main negative regulator, Mdm2, which inhibits p53's transcriptional activity and targets it for degradation via the proteasome pathway. The closely related Mdm2 homolog, MdmX, is also considered to be a general inhibitor of transactivation by p53, through binding to the p53 activation domain. We show here that, unexpectedly, upon DNA damage and ribosomal stress, MdmX plays a positive role in p53-mediated activation of the Mdm2 gene, but not of numerous other p53 target genes including p21. Downregulation of MdmX results in lower levels of mature and nascent Mdm2 transcripts following cellular stress. This correlates with a longer p53 half-life following DNA damage. In vitro, Mdm2 inhibits the binding of p53 to DNA to a much greater extent than does MdmX, although MdmX does not stimulate p53 interaction with Mdm2 promoter DNA. Strikingly, however, MdmX is required for optimal p53 binding to the Mdm2 promoter in vivo. Thus, we have described a new mechanism by which MdmX can suppress p53, which is through transcriptional activation of p53's principal negative regulator, Mdm2.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22290440      PMCID: PMC3302446          DOI: 10.1128/MCB.06150-11

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  75 in total

1.  MDMX overexpression prevents p53 activation by the MDM2 inhibitor Nutlin.

Authors:  Baoli Hu; Daniele M Gilkes; Bilal Farooqi; Said M Sebti; Jiandong Chen
Journal:  J Biol Chem       Date:  2006-08-11       Impact factor: 5.157

2.  The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop.

Authors:  Xiongbin Lu; Ou Ma; Thuy-Ai Nguyen; Stephen N Jones; Moshe Oren; Lawrence A Donehower
Journal:  Cancer Cell       Date:  2007-10       Impact factor: 31.743

3.  RING domain-mediated interaction is a requirement for MDM2's E3 ligase activity.

Authors:  Hidehiko Kawai; Vanessa Lopez-Pajares; Mihee M Kim; Dmitri Wiederschain; Zhi-Min Yuan
Journal:  Cancer Res       Date:  2007-07-01       Impact factor: 12.701

Review 4.  Transcriptional control of human p53-regulated genes.

Authors:  Todd Riley; Eduardo Sontag; Patricia Chen; Arnold Levine
Journal:  Nat Rev Mol Cell Biol       Date:  2008-05       Impact factor: 94.444

5.  Monoubiquitinated H2B is associated with the transcribed region of highly expressed genes in human cells.

Authors:  Neri Minsky; Efrat Shema; Yair Field; Meromit Schuster; Eran Segal; Moshe Oren
Journal:  Nat Cell Biol       Date:  2008-03-16       Impact factor: 28.824

6.  The Wip1 phosphatase and Mdm2: cracking the "Wip" on p53 stability.

Authors:  Xiongbin Lu; Thuy-Ai Nguyen; X Zhang; Lawrence A Donehower
Journal:  Cell Cycle       Date:  2008-01-15       Impact factor: 4.534

7.  Quantitative analyses reveal the importance of regulated Hdmx degradation for p53 activation.

Authors:  Yunyuan V Wang; Mark Wade; Eetsin Wong; Yao-Cheng Li; Luo Wei Rodewald; Geoffrey M Wahl
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-17       Impact factor: 11.205

8.  Haploinsufficiency of Mdm2 and Mdm4 in tumorigenesis and development.

Authors:  Tamara Terzian; Yongxing Wang; Carolyn S Van Pelt; Neil F Box; Elisabeth L Travis; Guillermina Lozano
Journal:  Mol Cell Biol       Date:  2007-05-25       Impact factor: 4.272

9.  The activity of p53 is differentially regulated by Brm- and Brg1-containing SWI/SNF chromatin remodeling complexes.

Authors:  Yang Xu; Jin Zhang; Xinbin Chen
Journal:  J Biol Chem       Date:  2007-10-15       Impact factor: 5.157

10.  p53 and p73 display common and distinct requirements for sequence specific binding to DNA.

Authors:  Maria Lokshin; Yingchun Li; Christian Gaiddon; Carol Prives
Journal:  Nucleic Acids Res       Date:  2006-12-14       Impact factor: 16.971

View more
  16 in total

1.  Mdm2 and MdmX as Regulators of Gene Expression.

Authors:  Lynn Biderman; James L Manley; Carol Prives
Journal:  Genes Cancer       Date:  2012-03

Review 2.  Deubiquitinating enzyme regulation of the p53 pathway: A lesson from Otub1.

Authors:  Xiao-Xin Sun; Mu-Shui Dai
Journal:  World J Biol Chem       Date:  2014-05-26

Review 3.  The regulation of MDM2 oncogene and its impact on human cancers.

Authors:  Yuhan Zhao; Haiyang Yu; Wenwei Hu
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2014-01-03       Impact factor: 3.848

4.  MDM2, MDMX, and p73 regulate cell-cycle progression in the absence of wild-type p53.

Authors:  Alyssa M Klein; Lynn Biderman; David Tong; Bita Alaghebandan; Sakina A Plumber; Helen S Mueller; Anne van Vlimmeren; Chen Katz; Carol Prives
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-02       Impact factor: 11.205

5.  Evaluation of TP53 Pro72Arg and MDM2 SNP285-SNP309 polymorphisms in an Italian cohort of LFS suggestive patients lacking identifiable TP53 germline mutations.

Authors:  Francesca Ponti; Serena Corsini; Maria Gnoli; Elena Pedrini; Marina Mordenti; Luca Sangiorgi
Journal:  Fam Cancer       Date:  2016-10       Impact factor: 2.375

6.  Doxorubicin and 5-fluorouracil induced accumulation and transcriptional activity of p53 are independent of the phosphorylation at serine 15 in MCF-7 breast cancer cells.

Authors:  Matthew T Balmer; Ryan D Katz; Si Liao; James S Goodwine; Susannah Gal
Journal:  Cancer Biol Ther       Date:  2014-05-06       Impact factor: 4.742

7.  p53 Regulation Goes Live-Mdm2 and MdmX Co-Star: Lessons Learned from Mouse Modeling.

Authors:  Laura A Tollini; Yanping Zhang
Journal:  Genes Cancer       Date:  2012-03

8.  Protecting the genome from mdm2 and mdmx.

Authors:  Alexia N Melo; Christine M Eischen
Journal:  Genes Cancer       Date:  2012-03

Review 9.  Targeting p53-MDM2-MDMX loop for cancer therapy.

Authors:  Qi Zhang; Shelya X Zeng; Hua Lu
Journal:  Subcell Biochem       Date:  2014

10.  Loci influencing blood pressure identified using a cardiovascular gene-centric array.

Authors:  Santhi K Ganesh; Vinicius Tragante; Wei Guo; Yiran Guo; Matthew B Lanktree; Erin N Smith; Toby Johnson; Berta Almoguera Castillo; John Barnard; Jens Baumert; Yen-Pei Christy Chang; Clara C Elbers; Martin Farrall; Mary E Fischer; Nora Franceschini; Tom R Gaunt; Johannes M I H Gho; Christian Gieger; Yan Gong; Aaron Isaacs; Marcus E Kleber; Irene Mateo Leach; Caitrin W McDonough; Matthijs F L Meijs; Olle Mellander; Cliona M Molony; Ilja M Nolte; Sandosh Padmanabhan; Tom S Price; Ramakrishnan Rajagopalan; Jonathan Shaffer; Sonia Shah; Haiqing Shen; Nicole Soranzo; Peter J van der Most; Erik P A Van Iperen; Jessica Van Setten; Jessic A Van Setten; Judith M Vonk; Li Zhang; Amber L Beitelshees; Gerald S Berenson; Deepak L Bhatt; Jolanda M A Boer; Eric Boerwinkle; Ben Burkley; Amber Burt; Aravinda Chakravarti; Wei Chen; Rhonda M Cooper-Dehoff; Sean P Curtis; Albert Dreisbach; David Duggan; Georg B Ehret; Richard R Fabsitz; Myriam Fornage; Ervin Fox; Clement E Furlong; Ron T Gansevoort; Marten H Hofker; G Kees Hovingh; Susan A Kirkland; Kandice Kottke-Marchant; Abdullah Kutlar; Andrea Z Lacroix; Taimour Y Langaee; Yun R Li; Honghuang Lin; Kiang Liu; Steffi Maiwald; Rainer Malik; Gurunathan Murugesan; Christopher Newton-Cheh; Jeffery R O'Connell; N Charlotte Onland-Moret; Willem H Ouwehand; Walter Palmas; Brenda W Penninx; Carl J Pepine; Mary Pettinger; Joseph F Polak; Vasan S Ramachandran; Jane Ranchalis; Susan Redline; Paul M Ridker; Lynda M Rose; Hubert Scharnag; Nicholas J Schork; Daichi Shimbo; Alan R Shuldiner; Sathanur R Srinivasan; Ronald P Stolk; Herman A Taylor; Barbara Thorand; Mieke D Trip; Cornelia M van Duijn; W Monique Verschuren; Cisca Wijmenga; Bernhard R Winkelmann; Sharon Wyatt; J Hunter Young; Bernhard O Boehm; Mark J Caulfield; Daniel I Chasman; Karina W Davidson; Pieter A Doevendans; Garret A Fitzgerald; John G Gums; Hakon Hakonarson; Hans L Hillege; Thomas Illig; Gail P Jarvik; Julie A Johnson; John J P Kastelein; Wolfgang Koenig; Winfried März; Braxton D Mitchell; Sarah S Murray; Albertine J Oldehinkel; Daniel J Rader; Muredach P Reilly; Alex P Reiner; Eric E Schadt; Roy L Silverstein; Harold Snieder; Alice V Stanton; André G Uitterlinden; Pim van der Harst; Yvonne T van der Schouw; Nilesh J Samani; Andrew D Johnson; Patricia B Munroe; Paul I W de Bakker; Xiaofeng Zhu; Daniel Levy; Brendan J Keating; Folkert W Asselbergs
Journal:  Hum Mol Genet       Date:  2013-01-08       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.